126 related articles for article (PubMed ID: 1804424)
1. Argyrophilia in ovarian serous tumors. A comparative study in 127 epithelial ovarian tumors.
Lin M; Hanai J; Wada A; Ozaki M; Nasu K; Okamoto S; Matsumoto K
Histol Histopathol; 1991 Oct; 6(4):477-84. PubMed ID: 1804424
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of HNK-1-defined antigen in gynecologic tumors with argyrophilia.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Abe Y; Tanizawa O
Int J Gynecol Pathol; 1986; 5(2):143-50. PubMed ID: 2424852
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in ovarian mucinous tumors.
Jiang C; Tan Y; Li E; Zhang D
Chin Med J (Engl); 2000 Jan; 113(1):70-4. PubMed ID: 11775215
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistological demonstration of peptide hormones and serotonin in ovarian mucinous and endometrioid tumors with argyrophil cells].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Nishino T; Saito J; Abe Y; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):361-5. PubMed ID: 2871119
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of neuroendocrine cells in gynecologic tumors.
Ueda G; Shimizu C; Saito J; Inoue Y; Tanaka Y; Inoue M; Tanizawa O
Int J Gynaecol Obstet; 1989 Jun; 29(2):165-72. PubMed ID: 2568293
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical localization of estradiol in malignant epithelial tumors of the ovary].
Takamizawa M; Yaoi Y; Kumasaka T; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):359-66. PubMed ID: 3559322
[TBL] [Abstract][Full Text] [Related]
7. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
9. Human ovarian tumors express gamma-glutamyl transpeptidase.
Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT
Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206
[TBL] [Abstract][Full Text] [Related]
10. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
11. S-100 protein in ovarian tumors. A comparative immunohistochemical study of 135 cases.
Lin M; Hanai J; Wada A; Ozaki M; Nasu K; Okamoto S; Matsumoto K
Acta Pathol Jpn; 1991 Mar; 41(3):233-9. PubMed ID: 2068948
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
13. Changes in expression of differentiation markers between normal ovarian cells and derived tumors.
Van Niekerk CC; Ramaekers FC; Hanselaar AG; Aldeweireldt J; Poels LG
Am J Pathol; 1993 Jan; 142(1):157-77. PubMed ID: 7678716
[TBL] [Abstract][Full Text] [Related]
14. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomics of ovarian epithelial tumors.
An HJ; Kim DS; Park YK; Kim SK; Choi YP; Kang S; Ding B; Cho NH
J Proteome Res; 2006 May; 5(5):1082-90. PubMed ID: 16674097
[TBL] [Abstract][Full Text] [Related]
16. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
17. Argyrophil cells in the endometrioid carcinoma of the ovary.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Inoue Y; Saito J; Nishino T; Kurachi K
Cancer; 1984 Oct; 54(8):1569-73. PubMed ID: 6206938
[TBL] [Abstract][Full Text] [Related]
18. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
19. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]